Understanding Microbial Dysbiosis as a Key Driver in Oral Squamous Cell Carcinoma Pathophysiology DOI

Vikram S. Amberkar,

Kochli Channappa Niranjan

International Journal of Histopathological Interpretation, Journal Year: 2024, Volume and Issue: 13(1), P. 22 - 27

Published: June 26, 2024

Oral squamous cell carcinoma (OSCC) presents a significant global health challenge, with established risk factors including tobacco use, alcohol consumption, and human papillomavirus (HPV) infection. Recent research has illuminated the role of oral microbiome in OSCC pathogenesis, highlighting microbial dysbiosis—a disruption balance—as potential contributor to disease development. This review examines how dysbiosis influences through altered composition, chronic inflammation, production carcinogenic metabolites, biofilm formation. Pathogenic bacteria like Fusobacterium nucleatum Porphyromonas gingivalis are implicated fostering pro-inflammatory milieu conducive carcinogenesis. Additionally, metabolites biofilms play crucial roles progression. The underscores promise biomarkers interventions such as probiotics, prebiotics, targeted antimicrobial therapies early detection therapeutic strategies for OSCC. Future directions should focus on optimizing these approaches improve clinical outcomes while minimizing unintended consequences associated modulation.

Language: Английский

Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer? DOI Creative Commons
Kenny Yeo,

Fangmeinuo Wu,

Runhao Li

et al.

Pathogens, Journal Year: 2024, Volume and Issue: 13(10), P. 826 - 826

Published: Sept. 24, 2024

The oral microbiome, studied by sampling the saliva or rinse, has been long thought to have diagnostic capacity for head and neck cancers (HNC). However, previous reports on HNC microbiome provide inconsistent results. aim of this study is consolidate these datasets determine microbial composition between patients healthy premalignant individuals. We analyzed 16 published cancer (HNC) short-read 16S rRNA sequencing datasets, specifically targeting V3V4, V4 V4V5 regions. These included rinse samples from donors with HNC, as well donors. Differences in diversities abundance were determined. displayed lower alpha diversity than In contrast, opposite trend was observed samples. Beta scores largely similar across different patient types. Similar phyla detected all samples, but proportions dependent sample type (i.e., rinse) primer set utilized sequencing.

Language: Английский

Citations

1

Impact of oral flora in tongue coating and saliva on oral cancer risk and the regulatory role of Interleukin-8 DOI
Xuemin Wang,

Xiaona Song,

Jiping Gao

et al.

Cytokine, Journal Year: 2024, Volume and Issue: 185, P. 156821 - 156821

Published: Dec. 3, 2024

Language: Английский

Citations

1

The oral microbiome and its role in oral squamous cell carcinoma: a systematic review of microbial alterations and potential biomarkers DOI Open Access

Angela Crispino,

Silvia Varricchio, Assunta Esposito

et al.

Pathologica, Journal Year: 2024, Volume and Issue: 116(6), P. 338 - 357

Published: Dec. 1, 2024

Oral squamous cell carcinoma (OSCC) is one of the most common cancers worldwide. Despite advances in diagnosis and treatment, incidence OSCC increasing, mortality rate remains high. This systematic review aims to examine potential association between composition oral microbiota OSCC.

Language: Английский

Citations

1

Understanding Microbial Dysbiosis as a Key Driver in Oral Squamous Cell Carcinoma Pathophysiology DOI

Vikram S. Amberkar,

Kochli Channappa Niranjan

International Journal of Histopathological Interpretation, Journal Year: 2024, Volume and Issue: 13(1), P. 22 - 27

Published: June 26, 2024

Oral squamous cell carcinoma (OSCC) presents a significant global health challenge, with established risk factors including tobacco use, alcohol consumption, and human papillomavirus (HPV) infection. Recent research has illuminated the role of oral microbiome in OSCC pathogenesis, highlighting microbial dysbiosis—a disruption balance—as potential contributor to disease development. This review examines how dysbiosis influences through altered composition, chronic inflammation, production carcinogenic metabolites, biofilm formation. Pathogenic bacteria like Fusobacterium nucleatum Porphyromonas gingivalis are implicated fostering pro-inflammatory milieu conducive carcinogenesis. Additionally, metabolites biofilms play crucial roles progression. The underscores promise biomarkers interventions such as probiotics, prebiotics, targeted antimicrobial therapies early detection therapeutic strategies for OSCC. Future directions should focus on optimizing these approaches improve clinical outcomes while minimizing unintended consequences associated modulation.

Language: Английский

Citations

0